The "Dream Changer": a randomized controlled trial evaluating the efficacy of a parent-based intervention for childhood nightmares.
children
insomnia
nightmares
nighttime fears
sleep
sleep anxiety
Journal
Sleep
ISSN: 1550-9109
Titre abrégé: Sleep
Pays: United States
ID NLM: 7809084
Informations de publication
Date de publication:
11 04 2022
11 04 2022
Historique:
received:
26
08
2021
revised:
16
11
2021
pubmed:
19
2
2022
medline:
13
4
2022
entrez:
18
2
2022
Statut:
ppublish
Résumé
Recurrent nightmares in childhood may have a range of detrimental effects for both the child and parents. This randomized controlled trial evaluated the efficacy of a novel parent-based intervention for childhood nightmares, using a new device called the "Dream Changer." A total of 56 children aged 3-10 years (M = 7.1 ± 2.1 years; 51.8% boys), and one of their parents were randomized to either the intervention or waitlist control group. The intervention group received a "Dream Changer"-a light-emitting remote-control-like device that the child was encouraged to take to bed and use upon experiencing a nightmare. Parents completed online surveys at baseline, 1-week, and 2-weeks following the intervention. Parents in the intervention group additionally completed a 3-month follow-up survey. Outcome variables included children's nightmare frequency, sleep-wake patterns, and sleep anxiety, as well as parents' daytime sleepiness. Significant group-by-time interaction effects were found for nightmare frequency (p = 0.001) and sleep anxiety (p = 0.006). Parents of children who received the "Dream Changer" reported fewer nightmares (Mdifference = 1.7, p < 0.001, d = 1.06) and decreased anxiety (Mdifference = 0.9, p = 0.001, d =0.41) at post-intervention, whereas such benefits were not found in the waitlist control group. Three-month follow-up assessments demonstrated that gains were maintained over-time. Interaction effects were not significant for children's sleep metrics or for parents' daytime sleepiness. The present study provides preliminary evidence for the efficacy of a brief, highly accessible intervention for reducing children's nightmares and nighttime anxiety. Future research may wish to test these effects using larger samples and longer follow-up assessments. The trial has been registered at the Australian New Zealand Clinical Trials Registry (https://www.anzctr.org.au/; Identifier:ACTRN12620000633987).
Identifiants
pubmed: 35179573
pii: 6531959
doi: 10.1093/sleep/zsac004
pii:
doi:
Banques de données
ANZCTR
['ACTRN12620000633987']
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© The Author(s) 2022. Published by Oxford University Press on behalf of Sleep Research Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.